12:15:39 EDT Tue 12 May 2026
Enter Symbol
or Name
USA
CA



TELYRX HOLDINGS INC SUBORDINATE VOTING S
Symbol TELY
Shares Issued 26,353,729
Close 2026-05-11 C$ 2.90
Market Cap C$ 76,425,814
Recent Sedar+ Documents

ORIGINAL: TelyRx to Host First Quarter 2026 Financial Results Conference Call on Wednesday, May 13, 2026 at 8:30 am ET

2026-05-12 10:46 ET - News Release

Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its first quarter 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market close on Tuesday, May 12, 2026.

Telephone Dial-In Access Information

The Company will host a conference call to discuss its first quarter of 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). To dial direct and enter the call through an operator, dial 647-361-0247 or 1-844-763-8274. The live webcast can be accessed https://www.gowebcasting.com/14710. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.

About TelyRx Holdings Inc.

TelyRx is a technology-enabled healthcare and pharmacy services company operating a digital pharmacy platform connecting patients with independent, state-licensed providers to access over 400 everyday medications across 48 U.S. states and territories. The company fulfills prescriptions through its licensed retail pharmacies and offers fast, convenient delivery of medications directly to patients' doors.

For additional information, visit www.telyrx.com or contact:

Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297139

© 2026 Canjex Publishing Ltd. All rights reserved.